Rethinking eligibility creep - 24/04/13
Doi : 10.1016/j.jaad.2008.02.041
Maryanne Kazanis, BA a, Craig Leonardi, MD b, Ken Gordon, MD c, Bruce Strober, MD, PhD d, Alan Menter, MD e, Alexa B. Kimball, MD, MPH f, ⁎
a Massachusetts General and Brigham and Women's Hospitals, Boston, Massachusetts
b Central Dermatology, St Louis, Missouri
c Northwestern University, Chicago, Illinois
d NYU Medical Center, New York, New York
e Texas Dermatology Associates, Dallas, Texas
f Harvard Medical School, Boston, Massachusetts
Correspondence to: Alexa B. Kimball, MD, MPH, Director, Clinical Unit for Research Trials in Skin (CURTIS), Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, #240, Boston, MA 02115.
Il testo completo di questo articolo è disponibile in PDF.
| Funding sources: None. |
|
| Disclosure: Dr Leonardi has been a member of the advisory board, a speaker, and an investigator for Amgen, Genentech, Centocor, and Abbott; a member of the advisory board and speaker for Warner-Chillcott; and an investigator for Bristol Myers. Dr Gordon has been a member of the advisory board, an investigator, and consultant for Abbott, Amgen, Centocor, and Genentech. Dr Strober has been a member of the advisory board, a speaker, and consultant for Abbott, Amgen, Centocor, Genentech, and Astellas. Dr Kimball has been an investigator, speaker, and consultant for Abbott, Centocor, and Amgen. Dr Menter has been a consultant, speaker, investigator, and member of the advisory board for Abbott, Amgen, Astellas, Centocor, Genentech, Warner Chilcott, and Wyeth. Ms Kazanis has no relevant conflicts of interest to declare. |
|
| Reprint requests: harvardskinstudies@partners.org |
© 2008
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 59 - N° 1
P. 165-167 - luglio 2008 Ritorno al numero
Articolo precedente
- Reply
- Peter Heald, Antonio Subtil, Deborah Breneman, Lynn D. Wilson
- Reply
- Steven R. Feldman
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?